These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18325461)

  • 1. Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure.
    Vrtovec B; Okrajsek R; Golicnik A; Ferjan M; Starc V; Schlegel TT; Radovancevic B
    J Card Fail; 2008 Mar; 14(2):140-4. PubMed ID: 18325461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
    Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.
    Vrtovec B; Okrajsek R; Golicnik A; Ferjan M; Starc V; Radovancevic B
    J Card Fail; 2005 Dec; 11(9):684-90. PubMed ID: 16360963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
    Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
    Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
    Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D
    Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.
    Bielecka-Dabrowa A; Goch JH; Mikhailidis DP; Rysz J; Maciejewski M; Banach M
    Med Sci Monit; 2009 Dec; 15(12):MS12-23. PubMed ID: 19946241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes does not affect ventricular repolarization and sudden cardiac death risk in patients with dilated cardiomyopathy.
    Vrtovec B; Fister M; Poglajen G; Starc V; Haddad F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S146-50. PubMed ID: 19250080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery.
    Song YB; On YK; Kim JH; Shin DH; Kim JS; Sung J; Lee SH; Kim WS; Lee YT
    Am Heart J; 2008 Aug; 156(2):373.e9-16. PubMed ID: 18657672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Lamas GA
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report.
    Fukuta H; Sane DC; Brucks S; Little WC
    Circulation; 2005 Jul; 112(3):357-63. PubMed ID: 16009792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
    Mozaffarian D; Minami E; Letterer RA; Lawler RL; McDonald GB; Levy WC
    Am J Cardiol; 2005 Dec; 96(12):1699-704. PubMed ID: 16360360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
    Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
    J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
    Uretsky BF; Thygesen K; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L; Cleland JG
    J Card Fail; 2008 Oct; 14(8):670-5. PubMed ID: 18926439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise oscillatory ventilation may predict sudden cardiac death in heart failure patients.
    Guazzi M; Raimondo R; Vicenzi M; Arena R; Proserpio C; Sarzi Braga S; Pedretti R
    J Am Coll Cardiol; 2007 Jul; 50(4):299-308. PubMed ID: 17659196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy is associated with lower mortality among patients with severe heart failure.
    Mozaffarian D; Nye R; Levy WC
    Am J Cardiol; 2004 May; 93(9):1124-9. PubMed ID: 15110204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
    Horwich TB; MacLellan WR; Fonarow GC
    J Am Coll Cardiol; 2004 Feb; 43(4):642-8. PubMed ID: 14975476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.